SAN

85.43

-0.78%↓

MRK1

110.15

-0.59%↓

ARGX

803.6

+0.6%↑

PHIA

23.38

-0.38%↓

ONC.US

353.14

-0.92%↓

SAN

85.43

-0.78%↓

MRK1

110.15

-0.59%↓

ARGX

803.6

+0.6%↑

PHIA

23.38

-0.38%↓

ONC.US

353.14

-0.92%↓

SAN

85.43

-0.78%↓

MRK1

110.15

-0.59%↓

ARGX

803.6

+0.6%↑

PHIA

23.38

-0.38%↓

ONC.US

353.14

-0.92%↓

SAN

85.43

-0.78%↓

MRK1

110.15

-0.59%↓

ARGX

803.6

+0.6%↑

PHIA

23.38

-0.38%↓

ONC.US

353.14

-0.92%↓

SAN

85.43

-0.78%↓

MRK1

110.15

-0.59%↓

ARGX

803.6

+0.6%↑

PHIA

23.38

-0.38%↓

ONC.US

353.14

-0.92%↓

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

18.04 -2.7

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

17.98

Max

19.76

Põhinäitajad
By Trading Economics
Sissetulek	-46M
Müük	-21M
Kasumimarginaal	221.361
Töötajad	103
EBITDA	-44M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+24.19% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	25. nov 2025

Turustatistika
By TradingEconomics
Turukapital	943M
Eelmine avamishind	20.74
Eelmine sulgemishind	18.04

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. nov 2025, 23:36 UTC

Kuumad aktsiad

Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron

19. nov 2025, 22:13 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35 Billion, Posts Higher 1Q Revenue -- Update

19. nov 2025, 21:55 UTC

Suurimad hinnamuutused turgudel

Amgen Lung Cancer Drug Gets Full Approval From FDA

19. nov 2025, 21:43 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35 Billion

19. nov 2025, 23:55 UTC

Market Talk

Gold Rises on Possible Investment Demand -- Market Talk

19. nov 2025, 23:54 UTC

Market Talk

BHP Vicuna JV Offers Significant Copper Output, At a Cost -- Market Talk

19. nov 2025, 23:47 UTC

Tulu

Lenovo Group 2Q EPS $2.52 >0992.HK

19. nov 2025, 23:46 UTC

Tulu

Lenovo Group: Delivered Double-Digit Yr-on-Yr Rev Growth Across All Main Business Groups and Sales Geographies >0992.HK

19. nov 2025, 23:45 UTC

Tulu

Lenovo Group 2Q Rev $20.5B >0992.HK

19. nov 2025, 23:42 UTC

Market Talk

Nikkei May Rise After Nvidia's Strong Earnings Soothe Investors' Nerves -- Market Talk

19. nov 2025, 23:42 UTC

Market Talk

Global Equities Roundup: Market Talk

19. nov 2025, 23:41 UTC

Tulu

Lenovo Group 2Q Adj Net $512.0M Vs. $409.0M >0992.HK

19. nov 2025, 23:41 UTC

Tulu

Lenovo Group 2Q Net $340.0M Vs. Net $359.0M >0992.HK

19. nov 2025, 23:40 UTC

Tulu

Lenovo Group 2Q Rev $20.45B Vs. $17.85B >0992.HK

19. nov 2025, 22:55 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 4th Update

19. nov 2025, 22:41 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 3rd Update

19. nov 2025, 22:30 UTC

Omandamised, ülevõtmised, äriostud

CICC Seeks Trading Halt in Hong Kong, Shanghai Stock Exchange

19. nov 2025, 22:30 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- 2nd Update

19. nov 2025, 22:30 UTC

Omandamised, ülevõtmised, äriostud

CICC Plans to Acquire Brokerage Firms via Share-Swap Agreement

19. nov 2025, 22:27 UTC

Omandamised, ülevõtmised, äriostud

China International Capital Plans to Acquire Brokerage Firms Cinda Securities, Dongxing Securities

19. nov 2025, 22:08 UTC

Tulu

ZTO Express (Cayman) 3Q Rev $1.67B >ZTO

19. nov 2025, 22:00 UTC

Tulu

Investors Cheer Blockbuster Nvidia Earnings -- WSJ

19. nov 2025, 21:58 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35B, Posts Higher 1Q Rev -- Update

19. nov 2025, 21:52 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- Update

19. nov 2025, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. nov 2025, 21:49 UTC

Market Talk

Tulu

Nvidia Quiets Investor Fears With Ballooning Demand -- Market Talk

19. nov 2025, 21:38 UTC

Tulu

Nvidia Profits Soar, Countering Investor Jitters on AI Boom -- WSJ

19. nov 2025, 21:28 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks to Buy Chronosphere for $3.35B

19. nov 2025, 21:27 UTC

Omandamised, ülevõtmised, äriostud

Exact Sciences Stock Jumps on Reported Deal Interest from Abbott Laboratories -- Barrons.com

19. nov 2025, 21:24 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palo Alto Networks 1Q Next-Generation Security ARR $5.9 B >PANW

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

24.19% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR 24.19%

Kõrge 25 EUR

Madal 21 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.